Cost-effectiveness of two models of management for patients on chronic warfarin therapy - A Markov model analysis

Thrombosis and Haemostasis

Volumn 90, Issue 6, 2003, Pages 1106-1111

  You, Joyce H S ^a   Chan, Fredric W H ^a   Wong, Raymond S M ^b   Cheng, Gregory ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cost effectiveness; Markov model; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULATION; ARTICLE; BLEEDING; CHRONIC DRUG ADMINISTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG FATALITY; ECONOMIC EVALUATION; HEALTH CARE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH CENTER; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MEDICAL CARE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROBABILITY; PUBLIC HEALTH; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL; THROMBOEMBOLISM;

EID: 0346272860     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-06-0367     Document Type: Article

References (23)

1. Errichette AM, Holden A, Ansell J. Management of oral anticoagulant therapy. Experience with an anticoagulation clinic. Arch Intern Med 1984; 144: 1966-8.
2. Petty GW, Lennihan L, Mohr JP et al. Complications of long-term anticoagulation. Ann Neurol 1988; 23: 570-4.
3. Charney R, Leddomado E, Rose DN et al. Anticoagulation clinics and the monitoring of anticoagulation therapy. Int J Cardiol 1988; 18: 197-206.
4. Searbrook GR, Karp D, Schmitt DD et al. An outpatient anticoagulation protocol managed by a vascular nurse-clinician. Am J Surg 1990; 160: 501-5.
5. Cannegieter SC, Rosendaal FR, Wintzen AR et al. Optimal oral anticoagulation therapy in patients with mechanical heart valves. N Engl J Med 1995; 333: 11-7.
6. Cortelazzo S, Finazzi G, Viero P et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 1993; 69: 316-20.
7. Wilt VM, Gums JG, Ahmed OI et al. Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy 1995; 15: 732-9.
8. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998; 158: 1641-7.
9. Poli D, Antonucci E, Lombardi A et al. Low rate of bleeding and thrombotic complications of oral anticoagulant therapy independent of age in the real-practice of an anticoagulation clinic. Blood Coagul Fibrinolysis 2003; 14: 269-75.
10. Fihn SD, Callahan CM, Martin DC et al. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 1996; 124: 970-9.
11. Holm T, Lassen JF, Husted SE et al. A randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapy. J Intern Med 2002; 252: 322-31.
12. Finh SD, McDonell M, Martin D. Risk factors for complications of chronic anticoagulation: A multicenter study. Ann Intern Med 1993; 118: 511-20.
13. Palareti G, Leali N, Coccheri S et al. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996; 348: 423-8.
14. Van Der Meer FJM, Rosendaal FR, Vandenbroucke JP et al. Bleeding complications in oral anticoagulant therapy. Arch Intern Med 1993; 153: 1557-62.
15. Lanefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989; 87144-52.
16. Gitter MJ, Jaeger TM, Petterson TM et al. Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochester, Minnesota. Mayo Clinic Proc 1995; 70: 725-33.
17. Website: Hospital Authority, Hong Kong. [www.ha.org.hk]
18. Sonnenberg FA, Beck RJ. Markov models in Medical Decision Making: A practice guide. Med Decis Making 1993; 13: 322-38.
19. Ansell J, Dalen J, Bussey H et al. Managing oral anticoagulant therapy. Chest 2001; 119: 22S-38S.
20. Ludlam CA, Bennett B, Fox KA et al. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Blood Coagul Fibrinolysis 1995; 6: 273-85.
21. Yu HCM, Chan TYK, Critchley JAJH et al. Factors determining the maintenance dose of warfarin in Chinese patients. QJM 1996; 89(2): 127-35.
22. Chan TY. Drug interactions as a cause of over anticoagulation and bleedings in Chinese patients receiving warfarin. Int J Clin Pharm Ther 1998; 36: 403-5.
23. Chan TY. Adverse interactions between warfarin and nonsteroidal anti-inflammatory drugs: Mechanisms. Clinical significance, and avoidance. Ann Pharmacother 1995; 29: 1274-83.